CONTACT US

Add:4th Floor,Binhai New City Headquarters,Changle City,Fujian,China

Zip Code:350200
Tel:0591-28995902

Fax:0591-28995903

Mobile:173 4640 3193

E-mail:fjfuyin@fjfuyin.com

 

WeChat

可信组件

Copyright © 2018 Fujian Gospel Precision Medicine Development Co., Ltd.  All Rights Reserved.   闽ICP备18011183号-1

 Powered By:www.300.cn  Management

/
/
Fujian Province Precision Medicine Industry Innovation Center starts in Fuzhou Binhai New City

Fujian Province Precision Medicine Industry Innovation Center starts in Fuzhou Binhai New City

[Abstract]:
On the morning of April 1, Fujian Precision Medicine Industry Innovation Center officially started construction in Binhai New City, Fuzhou.

On the morning of April 1, Fujian Precision Medicine Industry Innovation Center officially started construction in Binhai New City, Fuzhou. At the same time, it held the signing ceremony of the Fuzhou City Precision Medicine Industry Development Forum and project.



 

The event was sponsored by the Fuzhou New District Administrative Committee. The Fujian Provincial Precision Medicine Industrial Innovation Center started construction and is a key project invested and built by Fujian Fushao Precision Medicine Development Co., Ltd. in Binhai New City, with a total investment of nearly 1.5 billion yuan. 120 acres, with a total construction area of 200,000 square meters, is planned to be completed within two years. It mainly undertakes the introduction of advanced medical R&D talents and units, and conducts clinical applications and industrial transformation of precision medical research such as genetics, oncology genomics, biological big data, precision immunotherapy, and tumor precise medical technology.





 


After the start of the construction ceremony, He Yuan Biotech (Shanghai) Co., Ltd., Fellow of the Royal Academy of Sciences, Professor Mai Dehua of the University of Toronto Professor of Medical Biophysics and Immunology, and Dr. Li Yong, the Special Expert of the Central Organization Department “Thousand People Program” Thirteen other units and teams signed a contract with Fuzhou Precision Medicine Development Co., Ltd. A total of 28 projects were launched in Fujian Province Precision Medicine Industry Innovation Center with a total valuation of approximately 12 billion. At the same time, seven strategic companies, namely the Sinopharm Group, the Hong Kong Bio-Pharmaceutical Innovation Association, the Taiwan Bio-industry Development Association, and the seven companies in the “Taiwan Three Areas,” signed a strategic cooperation agreement with Fusui Precision Medicine Development Co., Ltd.




Focusing on the theme of precision medicine development, Zhu Yangyong, director of the Center for Data Research from the School of Computer Science and Technology, Fudan University, brought a report titled “Exploration of the Open Data Sharing Model of Medical Data,” Shi Leming, director of the Fudan University Pharmacogenomics Research Center, entitled “ The Road to Precision Medicine: A Study of the Standardization of Big Data for Group Studies", executive vice president of the Hong Kong Biomedicine Innovation Association and Chairman of the Board of Directors of Henya Fund Zhou Boyyu made an article entitled "Interpretation of the policy for biopharmaceutical companies listed in Hong Kong" The report shared the wonderful views on precision medicine with the guests.
With the completion of a number of projects and the conclusion of strategic cooperation agreements, the future development base of the Fujian Precision Medicine Industry Innovation Center will be more solid.